The detection of neural autoantibodies in patients with antiepileptic‐drug‐resistant epilepsy predicts response to immunotherapy

Abstract

A significant proportion of patients with AED-resistant epilepsy harbor neural-specific autoantibodies. The detection of these antibodies, especially of those binding to synaptic antigens, may predict a favorable response to immunotherapy, thus overcoming AED resistance.